Literature DB >> 32216943

Are Immune Checkpoint Inhibitors Effective Against Uncommon Oncogene-Driven NSCLC Subtypes?

Iñaki Eguren-Santamaria1, Miguel F Sanmamed2, Ignacio Gil-Bazo3.   

Abstract

Entities:  

Year:  2020        PMID： 32216943     DOI： 10.1016/j.jtho.2020.02.003

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  1 in total

Review 1.  Non-Small-Cell Lung Cancer Patients with Coexistence of High PD-L1 Expression and RET Fusion-Which Path Should We Follow? Case Reports and Literature Review.

Authors:  Magdalena Knetki-Wróblewska; Kamila Wojas-Krawczyk; Dariusz M Kowalski; Maciej Krzakowski
Journal:  J Clin Med       Date:  2022-03-15       Impact factor: 4.241
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.